PepsiCo Adds Pharma Exec to Board

PURCHASE, N.Y. — PepsiCo, Inc. (NASDAQ: PEP) today announced Sept. 17 that its Board of Directors has elected Joaquin Duato as an independent member of the Board. Mr. Duato, 64, will join the Board effective December 1, 2026, and will be a member of the Audit Committee. Mr. Duato currently serves as Chairman and Chief Executive Officer of Johnson & Johnson, a global healthcare company.

“We look forward to working with Joaquin on the PepsiCo Board,” said PepsiCo Chairman and CEO Ramon Laguarta, in a press release. “During his more than three decades at Johnson & Johnson, he has played a key role in driving strategic transformation, portfolio optimization and innovation at the company, leading complex global businesses spanning pharmaceuticals, consumer health and technology. His broad leadership experience and perspective will be an important asset to the Board as PepsiCo continues to evolve its portfolio, invest in growth opportunities and strengthen its position as a global convenient food and beverage leader.”

Mr. Duato has served as Chairman of the Board and Chief Executive Officer of Johnson & Johnson since 2023 and 2022, respectively, and as a director since 2022. Prior to that, he served as Vice Chairman of the Executive Committee from 2018 to 2021 and Worldwide Chairman, Pharmaceuticals from 2011 to 2018. 

Author

  • Briefs and brand-related news from across the U.S. BrandlandUSA welcomes your news releases, including people changes, anniversaries and product revamps. Get in touch by emailing below.

    View all posts

Leave a Reply

Your email address will not be published. Required fields are marked *